208 related articles for article (PubMed ID: 9155263)
1. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.
Anderson C; Hrabovsky S; McKinley Y; Tubesing K; Tang HP; Dunbar R; Mukhtar H; Elmets CA
Photochem Photobiol; 1997 May; 65(5):895-901. PubMed ID: 9155263
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.
Reddan JC; Anderson CY; Xu H; Hrabovsky S; Freye K; Fairchild R; Tubesing KA; Elmets CA
Photochem Photobiol; 1999 Jul; 70(1):72-7. PubMed ID: 10420845
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.
Whitacre CM; Feyes DK; Satoh T; Grossmann J; Mulvihill JW; Mukhtar H; Oleinick NL
Clin Cancer Res; 2000 May; 6(5):2021-7. PubMed ID: 10815928
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
Azizuddin K; Kalka K; Chiu SM; Ahmad N; Mukhtar H; Separovic D
Int J Oncol; 2001 Feb; 18(2):411-5. PubMed ID: 11172611
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence.
Zaidi SI; Oleinick NL; Zaim MT; Mukhtar H
Photochem Photobiol; 1993 Dec; 58(6):771-6. PubMed ID: 8309997
[TBL] [Abstract][Full Text] [Related]
7. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
8. Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.
Baron ED; Malbasa CL; Santo-Domingo D; Fu P; Miller JD; Hanneman KK; Hsia AH; Oleinick NL; Colussi VC; Cooper KD
Lasers Surg Med; 2010 Dec; 42(10):728-35. PubMed ID: 21246576
[TBL] [Abstract][Full Text] [Related]
9. FADD null mouse embryonic fibroblasts undergo apoptosis after photosensitization with the silicon phthalocyanine Pc 4.
Nagy B; Yeh WC; Mak TW; Chiu SM; Separovic D
Arch Biochem Biophys; 2001 Jan; 385(1):194-202. PubMed ID: 11361017
[TBL] [Abstract][Full Text] [Related]
10. Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin.
van Geel IP; Oppelaar H; Oussoren YG; van der Valk MA; Stewart FA
Int J Cancer; 1995 Jan; 60(3):388-94. PubMed ID: 7829249
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin.
Agarwal R; Korman NJ; Mohan RR; Feyes DK; Jawed S; Zaim MT; Mukhtar H
Photochem Photobiol; 1996 Apr; 63(4):547-52. PubMed ID: 8934768
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic activities and skin photosensitivity of the bis(dimethylthexylsiloxy)silicon 2,3-naphthalocyanine in mice.
Brasseur N; Ouellet R; Lewis K; Potter WR; van Lier JE
Photochem Photobiol; 1995 Dec; 62(6):1058-65. PubMed ID: 8570740
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic cell killing effects and acute skin photosensitivity of aluminum-chloro-tetrasulfonated phthalocyanine and hematoporphyrin derivative.
Komatsu K
Jpn J Cancer Res; 1991 May; 82(5):599-606. PubMed ID: 1905706
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
16. Photofrin
Baran TM
Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
[TBL] [Abstract][Full Text] [Related]
17. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
[TBL] [Abstract][Full Text] [Related]
18. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
19. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
